Literature DB >> 29243132

HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review.

Bruno F Guedes1, Márcio A A Vieira Filho2, Clarice Listik2, Rafael B Carra2, Cristiane B Pereira2, Emanuelle R da Silva2, Hélio R Gomes2,3, José E Vidal4,5,6.   

Abstract

Opsoclonus-myoclonus-ataxia (OMA) syndrome is a debilitating autoimmune neurological disorder. Post-infectious opsoclonus-myoclonus-ataxia syndrome has been described with varying bacterial, spirochetal, and viral infections including several patients with HIV. However, specific immunopathological mechanisms that may lead to opsoclonus-myoclonus in HIV-positive patients are unknown.We report a case of HIV-associated opsoclonus-myoclonus and early HIV infection. A review of published literature shows opsoclonus-myoclonus can occur during early infection, in immune reconstitution syndrome or in association with other infections, especially tuberculosis.

Entities:  

Keywords:  Acute HIV infection; HIV; Immune reconstitution; Ocular flutter; Opsoclonus; Opsoclonus-myoclonus-ataxia

Mesh:

Substances:

Year:  2017        PMID: 29243132     DOI: 10.1007/s13365-017-0603-3

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  12 in total

1.  [Opsoclonus-myoclonus in a patient with AIDS: a good response to treatment with IV immunoglobulins].

Authors:  I García-Morales; J Porta-Etessam; R Saiz-Díaz; C Gómez-Escalonilla; L Galán; G Parrilla; J A Molina
Journal:  Rev Neurol       Date:  1999 Dec 16-31       Impact factor: 0.870

2.  Therapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection.

Authors:  Willem Joost Wiersinga; Jan M Prins; Diederik van de Beek
Journal:  Clin Infect Dis       Date:  2012-02-01       Impact factor: 9.079

3.  Opsoclonus-myoclonus-ataxia syndrome and HIV seroconversion.

Authors:  Ana Ayarza; Virginia Parisi; Javier Altclas; Daniela Visconti; Gabriel Persi; Carlos A Rugilo; Emilia M Gatto
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

4.  Ocular flutter in vidarabine toxicity.

Authors:  M Gizzi; S Rudolph; A Perakis
Journal:  Am J Ophthalmol       Date:  1990-01-15       Impact factor: 5.258

5.  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

Authors:  N G Pakker; D W Notermans; R J de Boer; M T Roos; F de Wolf; A Hill; J M Leonard; S A Danner; F Miedema; P T Schellekens
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

6.  HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases.

Authors:  Natlada Kanjanasut; Kammant Phanthumchinda; Roongroj Bhidayasiri
Journal:  Clin Neurol Neurosurg       Date:  2010-04-27       Impact factor: 1.876

7.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

8.  Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy--possible immune reconstitution inflammatory syndrome.

Authors:  Ronald van Toorn; Helena Rabie; James M Warwick
Journal:  Eur J Paediatr Neurol       Date:  2005-11-02       Impact factor: 3.140

9.  Opsoclonus-myoclonus-ataxia syndrome in an AIDS patient.

Authors:  Thiago Cardoso Vale; Rodrigo Alencar E Silva; Mauro César Quintão E Silva Cunningham; Débora Palma Maia; Sarah Teixeira Camargos; Francisco Cardoso
Journal:  Einstein (Sao Paulo)       Date:  2013-12

10.  Opsoclonus-myoclonus-ataxia syndrome in an HIV-infected child.

Authors:  Noella Maria Delia Pereira; Ira Shah; Shilpa Kulkarni
Journal:  Oxf Med Case Reports       Date:  2016-10-01
View more
  6 in total

1.  Opsoclonus-myoclonus syndrome with severe clinical course and beneficial outcome: A case report.

Authors:  Ewa Koziorowska-Gawron; Magdalena Koszewicz; Joanna Bladowska; Maria Ejma; Slawomir Budrewicz
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

2.  CSF HIV RNA Escape in Opsoclonus-Myoclonus-Ataxia Syndrome: Case Report and Review of the Literature.

Authors:  Pierre Cabaraux; Arthur Poncelet; Jérome Honnorat; Remy Demeester; Soraya Cherifi; Mario Manto
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

Review 3.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

Review 4.  Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective.

Authors:  Alvin Pumelele Ndondo; Brian Eley; Jo Madeleine Wilmshurst; Angelina Kakooza-Mwesige; Maria Pia Giannoccaro; Hugh J Willison; Pedro M Rodríguez Cruz; Jeannine M Heckmann; Kathleen Bateman; Angela Vincent
Journal:  Front Immunol       Date:  2022-03-09       Impact factor: 7.561

Review 5.  Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.

Authors:  Jason L Chan; Keely A Murphy; Justyna R Sarna
Journal:  J Neurol       Date:  2021-02-22       Impact factor: 4.849

6.  Generalised myoclonus associated with COVID-19 infection.

Authors:  Aatma Ram; Hafiz Jeelani; Dilpat Kumar; Heeren Patel
Journal:  BMJ Case Rep       Date:  2021-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.